Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Xcel Energy Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while Xcel Energy Inc trades at $75.69 (market cap $47.07B). The key difference: Xcel Energy Inc is far larger — about 6.6× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Xcel Energy Inc pays a 3.14% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Xcel Energy Inc for 61 Days on average.
| IONS | XEL | |
|---|---|---|
Market Cap | $7.10B | $47.07B |
Volume | 2,027,457 | 4,542,292 |
Sector | Health | Utilities |
52-Week High | $86.50 | $83.91 |
52-Week Low | $42.38 | $69.39 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $6.66B | $85.39B |
Dividend Yield | — | 3.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XEL trades at $74.64, up 0.63% today, with a bullish technical signal and strong analyst support. Recent earnings show mixed results, with a Q2 2026 beat but a Q4 2025 miss. The company maintains solid profitability with a 15.28% net income margin and benefits from rising power demand linked to data center growth, as highlighted by recent partnerships like the electric school bus launch with Jeffco Public Schools.
The outlook is positive, driven by a $60 billion capital expenditure plan and robust data center demand, supporting an 11% annual rate base growth. Key risks include wildfire liabilities, high debt levels, and execution of the massive spending plan. The consensus price target of $90.08 suggests ~21% upside, but investors must weigh growth against regulatory and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
